
EW
Edwards Lifesciences CorporationNYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
43.99
PEG
—
P/B
4.55
P/S
7.76
EV/EBITDA
32.23
DCF Value
$61.65
FCF Yield
2.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.1%
Operating Margin
26.7%
Net Margin
17.6%
ROE
10.4%
ROA
9.9%
ROIC
11.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.57B | $91.2M | $0.16 |
| FY 2025 | $6.07B | $1.07B | $1.83 |
| Q3 2025 | $1.55B | $291.1M | $0.50 |
| Q2 2025 | $1.53B | $329.8M | $0.56 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.94
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.